Is Spotify a Millionaire-Maker Stock?
Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…
Sell
39
YMAB Quote, Financials, Valuation and Earnings
Last price:
$3.88
Seasonality move
:
13.57%
Day range:
$3.87 - $4.26
52-week range:
$3.76 - $16.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.97x
P/B ratio:
1.91x
Volume:
444.2K
Avg. volume:
257.1K
1-year change:
-69.77%
Market cap:
$176.1M
Revenue:
$87.7M
EPS (TTM):
-$0.67
Earnings Data
Next earnings date for YMAB
May 13
2025
Most recent earnings per share
-$0.15
Missed by $0.02
(Mar 4/2025)
Consensus Estimate
-$0.13
(Mar 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
YMAB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $20.4M | -- | -- | -$0.23 | -- |
| 05/13/2025 | Q1 | $19.6M | -- | -- | -$0.20 | -- |
| 03/04/2025 | Q4 | $26.7M | $26.5M | -$0.15 | -$0.13 | -$0.02 |
| 11/08/2024 | Q3 | $23.3M | $18.5M | -$0.16 | -$0.15 | -$0.01 |
| 08/12/2024 | Q2 | $23M | $22.8M | -$0.21 | -$0.12 | -$0.09 |
| 05/07/2024 | Q1 | $22.2M | $19.9M | -$0.15 | -$0.13 | -$0.02 |
| 02/29/2024 | Q4 | $21M | $23.4M | -$0.02 | -$0.18 | $0.16 |
| 11/13/2023 | Q3 | -- | -- | -$0.18 | -$0.18 | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.14 | -$0.24 | $0.10 |
| 05/08/2023 | Q1 | -- | -- | -$0.15 | -$0.31 | $0.16 |
| 03/30/2023 | Q4 | -- | -- | $0.03 | -$0.41 | $0.44 |
| 11/07/2022 | Q3 | -- | -- | -$0.63 | -$0.70 | $0.07 |
| 08/08/2022 | Q2 | -- | -- | -$0.94 | -$0.65 | -$0.29 |
| 05/09/2022 | Q1 | -- | -- | -$0.64 | -$0.67 | $0.03 |
| 02/24/2022 | Q4 | -- | -- | -$0.85 | -$0.69 | -$0.16 |
| 11/04/2021 | Q3 | -- | -- | -$0.66 | -$0.58 | -$0.08 |
| 08/05/2021 | Q2 | -- | -- | -$0.53 | -$0.64 | $0.11 |
| 05/06/2021 | Q1 | -- | -- | $0.75 | $0.62 | $0.13 |
| 02/25/2021 | Q4 | -- | -- | -$0.48 | -$0.54 | $0.06 |
| 11/05/2020 | Q3 | -- | -- | -$0.82 | -$0.77 | -$0.05 |
| 08/06/2020 | Q2 | -- | -- | -$1.01 | -$0.66 | -$0.35 |
| 05/07/2020 | Q1 | -- | -- | -$0.66 | -$0.61 | -$0.05 |
| 03/12/2020 | Q4 | -- | -- | -$0.61 | -$0.65 | $0.04 |
| 11/13/2019 | Q3 | -- | -- | -$0.70 | -$0.54 | -$0.16 |
| 08/14/2019 | Q2 | -- | -- | -$0.53 | -$0.49 | -$0.04 |
| 05/10/2019 | Q1 | -- | -- | -$0.47 | -$0.39 | -$0.08 |
| 03/22/2019 | Q4 | -- | -- | -$0.42 | -$0.34 | -$0.08 |
| 11/13/2018 | Q3 | -- | -- | -$0.42 | -$0.36 | -$0.06 |
Y-mAbs Therapeutics Earnings Questions
-
How Much did Y-mAbs Therapeutics Generate in Revenue Last Quarter?
Y-mAbs Therapeutics reported $26.5M worth of top line sales in its most recent quarter.
-
Did Y-mAbs Therapeutics Beat Earnings Last Quarter?
Y-mAbs Therapeutics announced earnings per share of -$0.15 which represents a miss of analyst forecast a -$0.13 per share.
-
Is Y-mAbs Therapeutics Profitable?
Y-mAbs Therapeutics reported $18.7M that represents $0.42 per share over the last quarter.
-
What is the Analyst Consensus for Y-mAbs Therapeutics EPS Next Year?
Y-mAbs Therapeutics's earnings are forecast to decrease from -$0.67 per share to -$0.58 per share next year representing a decrease of -39.64%.
-
When is Y-mAbs Therapeutics's Earnings Date?
Y-mAbs Therapeutics's next earnings date is May 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is a Millionaire-Maker Stock?
From time to time, investors will run across the term…
5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
